药物更新:最近的药物批准,2025年冬季版
The Nurse practitioner
|January 23, 2025
概括
美国FDA在2024年初批准了新药,用于初级保健医生. 这一更新涵盖了七种关键药物,包括sotatercept-csrk和resmetirom,帮助临床实践.
科学领域:
- 药品和治疗药品的制造业.
- 初级医疗保健医学 一级医疗保健医学
- 药物批准过程 药物批准过程
背景情况:
- 美国食品和药物管理局 (FDA) 在评估新药方面发挥着至关重要的作用.
- 初级保健机构需要及时更新新批准的药物,以有效管理患者.
- 该杂志每两年发布一次的药物更新,为医疗保健专业人员提供了必要的信息.
研究的目的:
- 审查和强调美国FDA在2024年上半年批准的新药.
- 为初级保健医生提供有关相关新药的简明信息.
- 作为2025年冬季药物更新的综合资源.
主要方法:
- 对2024年1月至6月的美国FDA药物批准数据的审查.
- 选择与初级保健实践有重大相关性的药物.
- 汇编了每个突出显示的药物的关键信息.
主要成果:
- 在2024年上半年,FDA批准了7种新药.
- 已批准的药物包括sotatercept-csrk (Winrevair),aprocitentan (Tryvio),resmetirom (Rezdiffra),berdazimer (Zelsuvmi),ceftobiprole medocaril sodium (Zevtera),sofpironium (Sofdra) 和ensifentrine (Ohtuvayre).这些药物被批准的药物包括sotatercept-csrk (Winrevair),aprocitentan (Tryvio),resmetirom (Rezdiffra),berdazimer (Zelsuvmi),ceftobiprole medocaril sodium (Zevtera),Sofpironium (Sofdra),以及Ensifentrine (Ohtuvayre),这些药物被批准的药物包括在内.
- 这些药物涵盖了一系列与初级保健相关的治疗领域.
结论:
- 初级保健医生应该了解这些最近获得FDA批准的药物.
- 这些新药的引入为患者治疗提供了潜在的进步.
- 这一更新有助于在初级保健机构做出明智的处方决定.
更多相关视频
10:13Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
Published on: November 8, 2024
2.0K
07:49Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions
Published on: September 17, 2014
11.5K
相关概念视频
Prescription, Nonprescription and Orphan Drugs
684
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
684
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Drug Classes and Categories
1.9K
Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
1.9K
Clinical Trials: Overview
2.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K
Drug Discovery: Overview
7.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.4K
Drug Nomenclature
1.6K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.6K
